Literature DB >> 31604531

VISTA: a novel immunotherapy target for normalizing innate and adaptive immunity.

Mohamed A ElTanbouly1, Walburga Croteau1, Randolph J Noelle2, J Louise Lines3.   

Abstract

V-domain Ig suppressor of T cell activation (VISTA) is a novel checkpoint regulator with limited homology to other B7 family members. The constitutive expression of VISTA on both the myeloid and T lymphocyte lineages coupled to its important role in regulating innate and adaptive immune responses, qualifies VISTA to be a promising target for immunotherapeutic intervention. Studies have shown differential impact of agonistic and antagonistic targeting of VISTA, providing a unique landscape for influencing the outcome of cancer and inflammatory diseases. Published by Elsevier Ltd.

Entities:  

Keywords:  Agonist; Antagonist; Autoimmunity; Cancer immunotherapy; Immune checkpoint; VISTA

Mesh：

Substances：

Year:  2019        PMID： 31604531      PMCID： PMC7233310          DOI： 10.1016/j.smim.2019.101308

Source DB:  PubMed          Journal:  Semin Immunol        ISSN： 1044-5323            Impact factor:   11.130


  59 in total

1.  Rab11 regulates exocytosis of recycling vesicles at the plasma membrane.

Authors:  Senye Takahashi; Keiji Kubo; Satoshi Waguri; Atsuko Yabashi; Hye-Won Shin; Yohei Katoh; Kazuhisa Nakayama
Journal:  J Cell Sci       Date:  2012-06-08       Impact factor: 5.285

2.  Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non-Small Cell Lung Cancer.

Authors:  Franz Villarroel-Espindola; Xiaoqing Yu; Ila Datar; Nikita Mani; Miguel Sanmamed; Vamsidhar Velcheti; Konstantinos Syrigos; Maria Toki; Hongyu Zhao; Lieping Chen; Roy S Herbst; Kurt A Schalper
Journal:  Clin Cancer Res       Date:  2017-12-04       Impact factor: 12.531

3.  A crucial role of the PD-1H coinhibitory receptor in suppressing experimental asthma.

Authors:  Huafeng Liu; Xin Li; Li Hu; Min Zhu; Bailin He; Liqun Luo; Lieping Chen
Journal:  Cell Mol Immunol       Date:  2017-05-08       Impact factor: 11.530

4.  Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53.

Authors:  Kyoung Wan Yoon; Sanguine Byun; Eunjeong Kwon; So-Young Hwang; Kiki Chu; Masatsugu Hiraki; Seung-Hee Jo; Astrid Weins; Samy Hakroush; Angelika Cebulla; David B Sykes; Anna Greka; Peter Mundel; David E Fisher; Anna Mandinova; Sam W Lee
Journal:  Science       Date:  2015-07-31       Impact factor: 47.728

5.  A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.

Authors:  Livnat Jerby-Arnon; Parin Shah; Michael S Cuoco; Christopher Rodman; Mei-Ju Su; Johannes C Melms; Rachel Leeson; Abhay Kanodia; Shaolin Mei; Jia-Ren Lin; Shu Wang; Bokang Rabasha; David Liu; Gao Zhang; Claire Margolais; Orr Ashenberg; Patrick A Ott; Elizabeth I Buchbinder; Rizwan Haq; F Stephen Hodi; Genevieve M Boland; Ryan J Sullivan; Dennie T Frederick; Benchun Miao; Tabea Moll; Keith T Flaherty; Meenhard Herlyn; Russell W Jenkins; Rohit Thummalapalli; Monika S Kowalczyk; Israel Cañadas; Bastian Schilling; Adam N R Cartwright; Adrienne M Luoma; Shruti Malu; Patrick Hwu; Chantale Bernatchez; Marie-Andrée Forget; David A Barbie; Alex K Shalek; Itay Tirosh; Peter K Sorger; Kai Wucherpfennig; Eliezer M Van Allen; Dirk Schadendorf; Bruce E Johnson; Asaf Rotem; Orit Rozenblatt-Rosen; Levi A Garraway; Charles H Yoon; Benjamin Izar; Aviv Regev
Journal:  Cell       Date:  2018-11-01       Impact factor: 41.582

6.  Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer.

Authors:  Jorge Blando; Anu Sharma; Maria Gisela Higa; Hao Zhao; Luis Vence; Shalini S Yadav; Jiseong Kim; Alejandro M Sepulveda; Michael Sharp; Anirban Maitra; Jennifer Wargo; Michael Tetzlaff; Russell Broaddus; Matthew H G Katz; Gauri R Varadhachary; Michael Overman; Huamin Wang; Cassian Yee; Chantale Bernatchez; Christine Iacobuzio-Donahue; Sreyashi Basu; James P Allison; Padmanee Sharma
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-11       Impact factor: 12.779

Review 7.  Mechanisms of resistance to immune checkpoint inhibitors.

Authors:  Russell W Jenkins; David A Barbie; Keith T Flaherty
Journal:  Br J Cancer       Date:  2018-01-02       Impact factor: 7.640

8.  C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.

Authors:  Lars Hornum; Anker Jon Hansen; Ditte Tornehave; Marianne Scheel Fjording; Paula Colmenero; Inger Falbe Wätjen; Niels Henrik Søe Nielsen; Henning Bliddal; Else Marie Bartels
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

9.  VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma.

Authors:  Ming Zhang; Hua-Jin Pang; Wei Zhao; Yu-Fa Li; Li-Xu Yan; Zhong-Yi Dong; Xiao-Feng He
Journal:  BMC Cancer       Date:  2018-05-02       Impact factor: 4.430

10.  Induction and transcriptional regulation of the co-inhibitory gene module in T cells.

Authors:  Norio Chihara; Asaf Madi; Takaaki Kondo; Huiyuan Zhang; Nandini Acharya; Meromit Singer; Jackson Nyman; Nemanja D Marjanovic; Monika S Kowalczyk; Chao Wang; Sema Kurtulus; Travis Law; Yasaman Etminan; James Nevin; Christopher D Buckley; Patrick R Burkett; Jason D Buenrostro; Orit Rozenblatt-Rosen; Ana C Anderson; Aviv Regev; Vijay K Kuchroo
Journal:  Nature       Date:  2018-06-13       Impact factor: 49.962
View more
  26 in total

Review 1.  Rethinking peripheral T cell tolerance: checkpoints across a T cell's journey.

Authors:  Mohamed A ElTanbouly; Randolph J Noelle
Journal:  Nat Rev Immunol       Date:  2020-10-19       Impact factor: 53.106

Review 2.  VISTA: Coming of age as a multi-lineage immune checkpoint.

Authors:  M A ElTanbouly; E Schaafsma; R J Noelle; J L Lines
Journal:  Clin Exp Immunol       Date:  2020-02-04       Impact factor: 4.330

Review 3.  The expanding role for small molecules in immuno-oncology.

Authors:  Rienk Offringa; Lisa Kötzner; Bayard Huck; Klaus Urbahns
Journal:  Nat Rev Drug Discov       Date:  2022-08-18       Impact factor: 112.288

Review 4.  Novel strategies in immune checkpoint inhibitor drug development: How far are we from the paradigm shift?

Authors:  Geoffrey Alan Watson; Jeffrey Doi; Aaron Richard Hansen; Anna Spreafico
Journal:  Br J Clin Pharmacol       Date:  2020-06-13       Impact factor: 4.335

5.  Immunologic alterations in the pancreatic cancer microenvironment of patients treated with neoadjuvant chemotherapy and radiotherapy.

Authors:  Matthew R Farren; Layal Sayegh; Michael Brandon Ware; Hsiao-Rong Chen; Jingjing Gong; Yan Liang; Alyssa Krasinskas; Shishir K Maithel; Mohammad Zaidi; Juan M Sarmiento; David Kooby; Pretesh Patel; Bassel El-Rayes; Walid Shaib; Gregory B Lesinski
Journal:  JCI Insight       Date:  2020-01-16

Review 6.  Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells.

Authors:  Benjamin Ruf; Bernd Heinrich; Tim F Greten
Journal:  Cell Mol Immunol       Date:  2020-11-24       Impact factor: 11.530

7.  Comparative Analysis and in vitro Experiments of Signatures and Prognostic Value of Immune Checkpoint Genes in Colorectal Cancer.

Authors:  Rui Ma; Xiujuan Qu; Xiaofang Che; Bowen Yang; Ce Li; Kezuo Hou; Tianshu Guo; Jiawen Xiao; Yunpeng Liu
Journal:  Onco Targets Ther       Date:  2021-05-31       Impact factor: 4.147

8.  VISTA regulates microglia homeostasis and myelin phagocytosis, and is associated with MS lesion pathology.

Authors:  Malte Borggrewe; Susanne M Kooistra; Evelyn M Wesseling; Fenja L Gierschek; Maaike L Brummer; Elizabeth C Nowak; Tiago Medeiros-Furquim; Tegan A Otto; Sam W Lee; Randolph J Noelle; Bart J L Eggen; Jon D Laman
Journal:  Acta Neuropathol Commun       Date:  2021-05-18       Impact factor: 7.801

9.  VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance.

Authors:  Mohamed A ElTanbouly; Yanding Zhao; Elizabeth Nowak; Jiannan Li; Evelien Schaafsma; Isabelle Le Mercier; Sabrina Ceeraz; J Louise Lines; Changwei Peng; Catherine Carriere; Xin Huang; Maria Day; Brent Koehn; Sam W Lee; Milagros Silva Morales; Kristin A Hogquist; Stephen C Jameson; Daniel Mueller; Jay Rothstein; Bruce R Blazar; Chao Cheng; Randolph J Noelle
Journal:  Science       Date:  2020-01-17       Impact factor: 63.714

Review 10.  Detection of Immune Checkpoint Receptors - A Current Challenge in Clinical Flow Cytometry.

Authors:  Benjamin Shibru; Katharina Fey; Stephan Fricke; André-René Blaudszun; Friederike Fürst; Max Weise; Sabine Seiffert; Maria Katharina Weyh; Ulrike Köhl; Ulrich Sack; Andreas Boldt
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.